Thrombopoietin induces an SH2-containing protein, CIS1, which binds to MP1

Involvement of the ubiquitin proteosome pathway

Seiichi Okabe, Tetsuzo Tauchi, Haruhiko Morita, Hideya Ohashi, Akihiko Yoshimura, Kazuma Ohyashiki

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

The interaction of thrombopoietin (TPO) with its receptor, Mpl, triggers growth and differentiation of megakaryocytes and their progenitors. The Mpl cytoplasmic domain controls this process through src homology 2 (SH2)- containing target molecules and their receptor docking sites. A novel cytokine inducible SH2-containing protein, CIS1, has been isolated. CIS1 is induced by interleukin-2 (IL-2), IL-3, GM-CSF, and erythropoietin (EPO), but not by IL-6, granulocyte colony-stimulating factor (G-CSF), or stem cell factor. To investigate the functional domains of Mpl for induction of CIS1, we examined FDCP-2 cell lines expressing seven carboxyl truncations of the human Mpl cytoplasmic domain. We found that the box1 and box2 regions of Mpl were necessary for induction of CIS1 after TPO stimulation. CIS1 was degraded very quickly and was found to be involved in the ubiquitin-proteosome pathway. A 4-hour depletion of TPO almost completely eliminated CIS1 protein; within 1 hour after TPO stimulation, CIS1 protein reappeared as 37- and 32- kDa proteins in the wild type Mpl-expressing FDCP-2 cells. Further, CIS1 was stably associated with tyrosine-phosphorylated Mpl. The SH2 domains of CIS1, constructed as glutathione S-transferase fusion protein, bound to activated Mpl in vitro. These results suggest that CIS1 may be an important signaling component downstream of Mpl and may regulate the proliferation and differentiation of hematopoietic cells.

Original languageEnglish
Pages (from-to)1542-1547
Number of pages6
JournalExperimental Hematology
Volume27
Issue number10
DOIs
Publication statusPublished - 1999 Oct
Externally publishedYes

Fingerprint

Thrombopoietin
Ubiquitin
Proteins
Megakaryocyte Progenitor Cells
Stem Cell Factor
src Homology Domains
Interleukin-3
Granulocyte Colony-Stimulating Factor
Granulocyte-Macrophage Colony-Stimulating Factor
Erythropoietin
Glutathione Transferase
Interleukin-2
Tyrosine
Cell Differentiation
Interleukin-6
Cytokines
Cell Line
Growth

Keywords

  • SH2-containing protein
  • Signal transduction
  • TPO

ASJC Scopus subject areas

  • Cancer Research
  • Cell Biology
  • Genetics
  • Hematology
  • Oncology
  • Transplantation

Cite this

Thrombopoietin induces an SH2-containing protein, CIS1, which binds to MP1 : Involvement of the ubiquitin proteosome pathway. / Okabe, Seiichi; Tauchi, Tetsuzo; Morita, Haruhiko; Ohashi, Hideya; Yoshimura, Akihiko; Ohyashiki, Kazuma.

In: Experimental Hematology, Vol. 27, No. 10, 10.1999, p. 1542-1547.

Research output: Contribution to journalArticle

Okabe, Seiichi ; Tauchi, Tetsuzo ; Morita, Haruhiko ; Ohashi, Hideya ; Yoshimura, Akihiko ; Ohyashiki, Kazuma. / Thrombopoietin induces an SH2-containing protein, CIS1, which binds to MP1 : Involvement of the ubiquitin proteosome pathway. In: Experimental Hematology. 1999 ; Vol. 27, No. 10. pp. 1542-1547.
@article{cec0140371d349b3bb599d7ea0256082,
title = "Thrombopoietin induces an SH2-containing protein, CIS1, which binds to MP1: Involvement of the ubiquitin proteosome pathway",
abstract = "The interaction of thrombopoietin (TPO) with its receptor, Mpl, triggers growth and differentiation of megakaryocytes and their progenitors. The Mpl cytoplasmic domain controls this process through src homology 2 (SH2)- containing target molecules and their receptor docking sites. A novel cytokine inducible SH2-containing protein, CIS1, has been isolated. CIS1 is induced by interleukin-2 (IL-2), IL-3, GM-CSF, and erythropoietin (EPO), but not by IL-6, granulocyte colony-stimulating factor (G-CSF), or stem cell factor. To investigate the functional domains of Mpl for induction of CIS1, we examined FDCP-2 cell lines expressing seven carboxyl truncations of the human Mpl cytoplasmic domain. We found that the box1 and box2 regions of Mpl were necessary for induction of CIS1 after TPO stimulation. CIS1 was degraded very quickly and was found to be involved in the ubiquitin-proteosome pathway. A 4-hour depletion of TPO almost completely eliminated CIS1 protein; within 1 hour after TPO stimulation, CIS1 protein reappeared as 37- and 32- kDa proteins in the wild type Mpl-expressing FDCP-2 cells. Further, CIS1 was stably associated with tyrosine-phosphorylated Mpl. The SH2 domains of CIS1, constructed as glutathione S-transferase fusion protein, bound to activated Mpl in vitro. These results suggest that CIS1 may be an important signaling component downstream of Mpl and may regulate the proliferation and differentiation of hematopoietic cells.",
keywords = "SH2-containing protein, Signal transduction, TPO",
author = "Seiichi Okabe and Tetsuzo Tauchi and Haruhiko Morita and Hideya Ohashi and Akihiko Yoshimura and Kazuma Ohyashiki",
year = "1999",
month = "10",
doi = "10.1016/S0301-472X(99)00094-6",
language = "English",
volume = "27",
pages = "1542--1547",
journal = "Experimental Hematology",
issn = "0301-472X",
publisher = "Elsevier Inc.",
number = "10",

}

TY - JOUR

T1 - Thrombopoietin induces an SH2-containing protein, CIS1, which binds to MP1

T2 - Involvement of the ubiquitin proteosome pathway

AU - Okabe, Seiichi

AU - Tauchi, Tetsuzo

AU - Morita, Haruhiko

AU - Ohashi, Hideya

AU - Yoshimura, Akihiko

AU - Ohyashiki, Kazuma

PY - 1999/10

Y1 - 1999/10

N2 - The interaction of thrombopoietin (TPO) with its receptor, Mpl, triggers growth and differentiation of megakaryocytes and their progenitors. The Mpl cytoplasmic domain controls this process through src homology 2 (SH2)- containing target molecules and their receptor docking sites. A novel cytokine inducible SH2-containing protein, CIS1, has been isolated. CIS1 is induced by interleukin-2 (IL-2), IL-3, GM-CSF, and erythropoietin (EPO), but not by IL-6, granulocyte colony-stimulating factor (G-CSF), or stem cell factor. To investigate the functional domains of Mpl for induction of CIS1, we examined FDCP-2 cell lines expressing seven carboxyl truncations of the human Mpl cytoplasmic domain. We found that the box1 and box2 regions of Mpl were necessary for induction of CIS1 after TPO stimulation. CIS1 was degraded very quickly and was found to be involved in the ubiquitin-proteosome pathway. A 4-hour depletion of TPO almost completely eliminated CIS1 protein; within 1 hour after TPO stimulation, CIS1 protein reappeared as 37- and 32- kDa proteins in the wild type Mpl-expressing FDCP-2 cells. Further, CIS1 was stably associated with tyrosine-phosphorylated Mpl. The SH2 domains of CIS1, constructed as glutathione S-transferase fusion protein, bound to activated Mpl in vitro. These results suggest that CIS1 may be an important signaling component downstream of Mpl and may regulate the proliferation and differentiation of hematopoietic cells.

AB - The interaction of thrombopoietin (TPO) with its receptor, Mpl, triggers growth and differentiation of megakaryocytes and their progenitors. The Mpl cytoplasmic domain controls this process through src homology 2 (SH2)- containing target molecules and their receptor docking sites. A novel cytokine inducible SH2-containing protein, CIS1, has been isolated. CIS1 is induced by interleukin-2 (IL-2), IL-3, GM-CSF, and erythropoietin (EPO), but not by IL-6, granulocyte colony-stimulating factor (G-CSF), or stem cell factor. To investigate the functional domains of Mpl for induction of CIS1, we examined FDCP-2 cell lines expressing seven carboxyl truncations of the human Mpl cytoplasmic domain. We found that the box1 and box2 regions of Mpl were necessary for induction of CIS1 after TPO stimulation. CIS1 was degraded very quickly and was found to be involved in the ubiquitin-proteosome pathway. A 4-hour depletion of TPO almost completely eliminated CIS1 protein; within 1 hour after TPO stimulation, CIS1 protein reappeared as 37- and 32- kDa proteins in the wild type Mpl-expressing FDCP-2 cells. Further, CIS1 was stably associated with tyrosine-phosphorylated Mpl. The SH2 domains of CIS1, constructed as glutathione S-transferase fusion protein, bound to activated Mpl in vitro. These results suggest that CIS1 may be an important signaling component downstream of Mpl and may regulate the proliferation and differentiation of hematopoietic cells.

KW - SH2-containing protein

KW - Signal transduction

KW - TPO

UR - http://www.scopus.com/inward/record.url?scp=0032853513&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032853513&partnerID=8YFLogxK

U2 - 10.1016/S0301-472X(99)00094-6

DO - 10.1016/S0301-472X(99)00094-6

M3 - Article

VL - 27

SP - 1542

EP - 1547

JO - Experimental Hematology

JF - Experimental Hematology

SN - 0301-472X

IS - 10

ER -